Navigation Links
NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance
Date:11/1/2007

e

NPS reported net income of $14.1 million for the third quarter of 2007 and ended the quarter with $302.2 million in cash and marketable securities. During the third quarter the following financial transactions were executed:

-- NPS granted Nycomed the rights to develop and market GATTEX outside

North America, which generated an up-front payment of $10 million;

-- NPS sold $11 million of Preotact(R) bulk drug supply to Nycomed;

-- The Preotact royalty entitlement was sold to Drug Royalty LP 3 for an

up-front payment of $50 million;

-- $50 million of convertible notes were issued to Visium Asset

Management;

-- $100 million in Sensipar(R) royalty-backed notes were issued;

-- $20.2 million of 3% Convertible Notes were repurchased for $19.5

million.

Subsequent to the close of the third quarter the following transactions were completed:

-- NPS sold its interests in the mGluR research and development program

to partner AstraZeneca for $30 million;

-- $171.2 million of its outstanding 3% Convertible Notes were repurchased

through a cash tender offer for $169.1 million;

-- Nycomed elected to proceed with the GATTEX licensing agreement,

triggering a $25 million additional upfront payment to NPS.

Excluding the net proceeds generated by new business development activities and financing transactions executed in 2007, NPS now expects to have a 2007 cash burn between $70 and $80 million, a change from its earlier guidance of $80 to $90 million. As a result of the reduced cash burn, recent transactions and gains on facilities sales, NPS is revising its previous year end cash balance guidance of $65 to $75 million to a new range of between $130 and $140 million.

NPS projects that its 2008 cash burn will be $35 to 45 million, as indicated in previous guidance. With the reduced cash burn and revised cash balance, NPS should have sufficient cash
'/>"/>

SOURCE NPS Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
4. Sonic Foundry reports GAAP loss as Q2 revenues rise
5. Fiserv reports $113.5 million in Q1 profit
6. Third Wave reports net loss of $18.9M for 2006
7. Musicnotes reports 45 percent growth in 2006
8. Sonic Foundry reports net loss, higher revenue
9. Sonic Foundry reports first cash-positive quarter
10. Merge Healthcare reports $10.8M net loss in Q3
11. Third Wave reports $5.2M third quarter loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... St. Louis, Missouri (PRWEB) December 23, 2014 ... and targeting Swiss biotechnology company, Syngenta, are in the ... for pretrial proceedings. The consolidated case is In Re: ... in the U.S. District Court for the District of ... litigation (MDL) has been handed over to U.S. District ...
(Date:12/24/2014)... The report provides basic ... definition, classification, application and industry overview. This ... and product cost structure. Production is separated ... also covers upstream raw materials, equipment, downstream ... and proposals. In the end, the export ...
(Date:12/24/2014)... Vermillion, Inc. (Nasdaq:   VRML), a ... today that investors including Oracle Investment Management, ... several Vermillion directors have agreed to purchase approximately ... stock and warrants to purchase unregistered shares of ... Under the terms of the private ...
(Date:12/22/2014)... 22, 2014 The Center for ... of technical training across the life sciences industry, has ... (SCDM) to provide the organization's members with discounted ... access to the more than 350 sessions across 80 ... 10% off when registering for a public course ...
Breaking Biology Technology:Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3
... , , BRUSSELS, December 14 ... Assessing the Lifestyles of,Women With Rheumatoid Arthritis in Seven Major Industrialized Countries , , ... disease, impacts their enjoyment of the festive season, ... preparing holiday food, writing cards and wrapping presents most, ...
... have discovered a new explanation for differences in the severity of ... gene, the more serious the handicap. The genetic defect is situated ... amount of copies of the GDI1 gene that is responsible. The ... Genetics , and are the result of work by the group ...
... , , DAVIS, Calif., Dec. 11 ... to its executive management team. Mr. Chris Hildreth joined ... is responsible for expanding all commercial aspects of the ... Kin Sing (Ray) Lam joined MBI as Vice President ...
Cached Biology Technology:Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Amount of gene surplus determines severity of mental retardation in males 2Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3
(Date:12/19/2014)... 2014 Research and Markets ( ... "iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... in July 2012, Apple introduced the fingerprint reading ... the only device of Apple incorporating such a ...
(Date:12/19/2014)... 2014  23andMe, Inc., the leading personal genetics company, ... fine-scale differences in genetic ancestry of individuals from across ... Since immigrants first arrived more than four hundred years ... served as a meeting place for peoples from different ... ongoing mixing of peoples with African, European, and American ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ... "Samsung Galaxy S5 - Home Button Synaptics Fingerprint ... http://photos.prnewswire.com/prnh/20130307/600769 ... than the iPhone 5S, Samsung introduces for the ... The Galaxy S5 home button presents ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... Northwest National Laboratory scientists have used electrostatic attraction ... carbon nanotubes. , This configuration can accommodate ... monitoring to infectious-agent detection, said Yuehe Lin, who ... campus' W.R. Wiley Environmental Molecular Sciences Laboratory. ...
... a vaccine designed to fight avian influenza will begin this ... is part of a multicenter trial that will test a ... whether the vaccine still triggers a strong immune response at ... the National Institute of Allergy and Infectious Diseases of the ...
... online today in the journal Nature Methods, researchers at ... powerful new tool that will facilitate genetic research and ... genetic disease. , The researchers have combined several ... lentiviral vector ?a gene delivery system partly derived from ...
Cached Biology News:A biosensor layered like lasagna 2Duke to test bird flu vaccine dosing 2Swiss researchers develop all-in-one remote control gene expression tool 2
... assay system offers the following ... for batch-processing systems, Long lasting ... microplates such as 384-well and ... storage conditions ( 2 - ...
Functionally tested for consistent G-banding of chromosomes....
...
Schneider's Drosophila Medium is formulated for the expression of heterologous proteins in Drosophila S2 cells....
Biology Products: